Short answer
There's no universal "safe" number of units for a random blood sugar (RBS) of 300 mg/dL - it depends entirely on the individual patient's correction/insulin sensitivity factor, type of diabetes, total daily insulin dose, renal function, and whether other insulin doses are already "on board." 8 units is within the commonly used range for a glucose of 300 mg/dL in several standard hospital correction scales, but it can also be too much or too little for a specific patient.
Where 8 units fits on standard scales
| Source | BG 300 mg/dL correction dose |
|---|
| Common hospital sliding scale (e.g., Med Ed 101 protocol) | 8 units rapid-acting insulin for 300+ mg/dL |
| AAFP standard-intensity dosing | ~7 units |
| AAFP insulin-resistant dosing | ~10 units |
| AAFP insulin-sensitive dosing | ~4-5 units |
| Washington Manual correction factor rule | 1-2 units per 50 mg/dL above target (~150 mg/dL target) -> 3-6 units for most patients |
So 8 units sits in a reasonable band, closer to what you'd use for someone who is insulin-resistant (obese, on high total daily dose, type 2 on large basal/bolus regimen) rather than someone insulin-sensitive (elderly, low body weight, renal impairment, type 1 diabetic, or someone who already received basal/bolus insulin recently) - Washington Manual of Medical Therapeutics, and AAFP glycemic control review.
Why "safe" can't be answered with a single number
- Insulin stacking risk - if the patient already got basal or a prior correction/meal dose of rapid-acting insulin within the last 2-4 hours, adding 8 more units on top can cause delayed hypoglycemia. This is the single biggest safety issue with ad-hoc sliding-scale dosing.
- Correction factor (ISF) varies by patient - calculated roughly as 1500/total daily dose (regular insulin) or 1800/total daily dose (rapid-acting). A patient on a low total daily dose (e.g., 20 units/day) has a much higher ISF (1 unit drops glucose ~75-90 mg/dL) than someone on 60 units/day (ISF ~25-30 mg/dL per unit) - Goodman & Gilman's Pharmacological Basis of Therapeutics.
- Renal impairment, elderly, NPO status, or recent hypoglycemia all lower the safe dose considerably.
- Sliding-scale insulin used alone (without basal coverage) is actively discouraged by surgical and critical care literature - it produces unpredictable swings between hyper- and hypoglycemia and is not recommended as sole inpatient management, especially when admission glucose is >180 mg/dL - Current Surgical Therapy, 14e; Barash's Clinical Anesthesia, 9e.
- Tintinalli's Emergency Medicine notes sliding-scale insulin orders "can lead to undesirable levels of hypoglycemia and hyperglycemia" and should not be used beyond 12-24 hours without transitioning to scheduled basal-bolus therapy.
Practical guidance
- If this is a one-off correction dose in a patient already on a basal-bolus regimen with a known correction factor, and no other rapid-acting insulin has been given recently, 8 units for a glucose of 300 is plausible and commonly used.
- If you don't know the patient's total daily dose, renal function, or whether insulin was already given, do not treat 8 units as automatically safe - verify no insulin stacking, confirm the patient is not NPO/at risk of not eating, and recheck glucose in 2-4 hours after a rapid-acting dose to monitor for hypoglycemia.
- For inpatients, current guidance favors basal-bolus regimens with a correction component individualized to the patient rather than a fixed sliding scale for everyone - a 2025 systematic review of hospital hyperglycemia guidelines (Wilson et al., Diabetes Care, PMID: 40117466) reinforces that scheduled basal-bolus insulin, not stand-alone sliding scale, is the preferred inpatient strategy.
If you can share the patient's total daily insulin dose, type of diabetes, weight, renal function, and whether any insulin was given in the last few hours, I can help estimate whether 8 units is an appropriate correction dose for that specific case.